These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26937172)

  • 21. Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro.
    Liang B; Zhan Y; Huang X; Gu E; Dai D; Cai J; Hu G
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):759-765. PubMed ID: 26542054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(11):689-723. PubMed ID: 19817501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms.
    Yu A; Kneller BM; Rettie AE; Haining RL
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1291-300. PubMed ID: 12438554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation.
    Saito T; Gutiérrez Rico EM; Kikuchi A; Kaneko A; Kumondai M; Akai F; Saigusa D; Oda A; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2018 Dec; 33(6):250-257. PubMed ID: 30366777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and structural characterisation of common cytochrome P450 2D6 allelic variants-roles of Pro34 and Thr107 in catalysis and inhibition.
    Dong AN; Ahemad N; Pan Y; Palanisamy UD; Yiap BC; Ong CE
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):1015-1029. PubMed ID: 31025144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.
    Zhou Q; Yu XM; Lin HB; Wang L; Yun QZ; Hu SN; Wang DM
    Pharmacogenomics J; 2009 Dec; 9(6):380-94. PubMed ID: 19636337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity.
    Muroi Y; Saito T; Takahashi M; Sakuyama K; Niinuma Y; Ito M; Tsukada C; Ohta K; Endo Y; Oda A; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2014; 29(5):360-6. PubMed ID: 24647041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
    Zhou SF
    Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6.
    Kitada M
    Int J Clin Pharmacol Res; 2003; 23(1):31-5. PubMed ID: 14621071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.
    Bogni A; Monshouwer M; Moscone A; Hidestrand M; Ingelman-Sundberg M; Hartung T; Coecke S
    Toxicol In Vitro; 2005 Aug; 19(5):621-9. PubMed ID: 15893449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative research on the metabolism of metoprolol by four CYP2D6 allelic variants in vitro with LC-MS/MS.
    Yang Q; Sun J; Li C; Zhang H; Xu W; Liu C; Zheng X
    J Pharm Biomed Anal; 2019 Sep; 174():479-485. PubMed ID: 31228851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Dynamics Simulations Reveal Structural Differences among Allelic Variants of Membrane-Anchored Cytochrome P450 2D6.
    Fischer A; Don CG; Smieško M
    J Chem Inf Model; 2018 Sep; 58(9):1962-1975. PubMed ID: 30126275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition.
    Niwa T; Murayama N; Yamazaki H
    Curr Drug Metab; 2011 Jun; 12(5):412-35. PubMed ID: 21453270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese.
    Ji L; Pan S; Marti-Jaun J; Hänseler E; Rentsch K; Hersberger M
    Clin Chem; 2002 Jul; 48(7):983-8. PubMed ID: 12089164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of P34S, G169R, R296C, and S486T Substitutions in Ligand Access and Catalysis for Cytochrome P450 2D6 Allelic Variants CYP2D6*14A and CYP2D6*14B.
    Dong AN; Ahemad N; Pan Y; Palanisamy UD; Yiap BC; Ong CE
    Drug Metab Bioanal Lett; 2022; 15(1):51-63. PubMed ID: 35049443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.
    Nishimura M; Ueda M; Saruwatari J; Nakashima H; Ogusu N; Aoki A; Tsuchimine S; Matsuda K; Iwashita K; Ono T; Oniki K; Shimoda K; Yasui-Furukori N
    Pharmacogenet Genomics; 2016 Sep; 26(9):403-13. PubMed ID: 27187662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
    Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
    Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.
    Zanger UM; Raimundo S; Eichelbaum M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):23-37. PubMed ID: 14618296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
    Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ
    Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients.
    Okubo M; Murayama N; Miura J; Chiba Y; Yamazaki H
    Biochem Pharmacol; 2015 Jan; 93(1):104-9. PubMed ID: 25475885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.